356 related articles for article (PubMed ID: 15068381)
1. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus infection of mice. I. Viral kinetics and histopathological changes in mice experimentally infected with coxsackieviruses B3 and B4 by oral route.
Bopegamage S; Borsanyiová M; Vargová A; Petrovicová A; Benkovicová M; Gomolcák P
Acta Virol; 2003; 47(4):245-51. PubMed ID: 15068380
[TBL] [Abstract][Full Text] [Related]
3. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
5. Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection.
Bopegamage S; Kovacova J; Vargova A; Motusova J; Petrovicova A; Benkovicova M; Gomolcak P; Bakkers J; van Kuppeveld F; Melchers WJG; Galama JM
J Gen Virol; 2005 Dec; 86(Pt 12):3271-3280. PubMed ID: 16298972
[TBL] [Abstract][Full Text] [Related]
6. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
7. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
[TBL] [Abstract][Full Text] [Related]
11. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3 infection and PBDE exposure causes organ-specific effects on CYP-gene expression in the mouse.
Lundgren M; Darnerud PO; Molin Y; Lilienthal H; Blomberg J; Ilbäck NG
Toxicology; 2007 Dec; 242(1-3):91-9. PubMed ID: 17964053
[TBL] [Abstract][Full Text] [Related]
14. Distribution of viral RNA in mouse tissues during acute phase of coxsackievirus B5 infection.
Moon MS; Joo CH; Hwang IS; Ye JS; Jun EJ; Lee HS; Kim D; Lee MJ; Lee H; Kim YK
Intervirology; 2005; 48(2-3):153-60. PubMed ID: 15812189
[TBL] [Abstract][Full Text] [Related]
15. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
Rabausch-Starz I; Neu N; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
[TBL] [Abstract][Full Text] [Related]
17. [Model of coxsackievirus B3 persistent infection in orally-inoculated BALB/c mouse].
Harrath R; Douche-Aourik F; Bourlet T; Ismail A; Omar S; Aouni M; Pozzetto B
Ann Biol Clin (Paris); 2004; 62(1):33-9. PubMed ID: 15047488
[TBL] [Abstract][Full Text] [Related]
18. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
[TBL] [Abstract][Full Text] [Related]
19. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains.
Klingel K; Kandolf R
Scand J Infect Dis Suppl; 1993; 88():79-85. PubMed ID: 8390720
[TBL] [Abstract][Full Text] [Related]
20. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
